In mice pre-selected for sacrifice at day 59 after tumor challenge (n = 3 per treatment group), MIS416 vaccination led to reduced tumor weight, while anti-CD11b mAb treatment had no significant effect at this time point (Fig. 5b). Here, ITGAM is linked to neoplasm.